化痰祛瘀法治疗晚期血吸虫病(巨脾型)患者的临床观察
本文选题:祛瘀化痰 + 晚期血吸虫病 ; 参考:《湖北中医药大学》2016年硕士论文
【摘要】:目的以“痰瘀阻络”为晚期血吸虫病(巨脾型)核心病机,突出“痰瘀互结”这一关键病理改变,将祛瘀化痰法的治则应用于晚期血吸虫病患者,观察其临床疗效,为从痰瘀阻络辩证论治晚期血吸虫病(巨脾型)患者提供临床依据。方法研究对象为2014年3月至2016年2月至荆州市区血吸虫防治所就诊的晚期血吸虫病(巨脾型)患者,以纳入和排除标准筛选后,共纳入64例。按随机数字方式分为对照组和治疗组,各32例。将两组患者治疗前的肝功能、中医症候积分等相关指标进行统计学对比,证明两组患者各项指标无统计学差异后开始临床观察。对照组采用晚期血吸虫病(巨脾型)临床路径给予患者治疗:消除病因及诱因治疗、保肝治疗(如还原型谷胱甘肽、复方甘草酸单铵)及对症支持治疗。治疗组在对照组治疗方案基础之上给予以浙贝、漏芦、郁金、丹参为主方的中药颗粒剂口服治疗,随证加减。治疗三个月后记录两组患者的肝纤维化、肝功能、B超、中医症候积分等相关指标,并将治疗前后及两组之间的数据进行统计学分析,观察药物的疗效和毒副反应。结果两组患者治疗前后总体疗效对比及总体中医症候积分对比无显著差异;在脾厚、肝门静脉直径、ALT的改善上两组患者之间没有显著差异。治疗组在中医症候积分上对呕吐、腹胀、尿黄的改善明显优于对照组;对AST、TBil、白蛋白(A)、LN的改善明显优于对照组;治疗组的起效速度明显快于对照组。结论祛瘀化痰法能有效改善晚期血吸虫病(巨脾型)患者的AST、TBil、白蛋白(A)、LN指标,并能有效缓解呕吐、腹胀、尿黄症状。
[Abstract]:Objective to take "phlegm and stasis blocking collaterals" as the core pathogenesis of advanced schistosomiasis (giant spleen type), to highlight the key pathological change of "phlegm and blood stasis mutual knot", and to apply the method of removing blood stasis and removing phlegm to patients with advanced schistosomiasis, and to observe its clinical effect. To provide clinical basis for the treatment of advanced schistosomiasis (giant spleen type) from phlegm and blood stasis obstruction of collaterals. Methods from March 2014 to February 2016, 64 patients with advanced schistosomiasis (giant spleen type) were included in the study. The patients were randomly divided into control group (32 cases) and treatment group (32 cases). The two groups of patients before treatment of liver function, TCM symptom score and other related indicators were statistically compared, it was proved that the two groups of patients after no statistical differences in each index began to clinical observation. The patients in the control group were treated with advanced schistosomiasis (giant spleen type) by clinical pathway: eliminating the etiology and inducement, protecting liver (such as reduced glutathione, compound ammonium glycyrrhizinate) and symptomatic support therapy. Treatment group on the basis of the control group on the basis of the treatment of Zhejiang shellfish, leaky Reed, Tujin, Danshen prescription of traditional Chinese medicine granules oral treatment, plus or minus with the syndrome. After three months of treatment, the liver fibrosis, liver function, B-ultrasound, TCM symptom score and other related indexes were recorded, and the data before and after treatment and between the two groups were statistically analyzed to observe the curative effect and side effects of drugs. Results there was no significant difference in total curative effect and total TCM symptom score between the two groups before and after treatment, but there was no significant difference between the two groups in spleen thickness, hepatic portal vein diameter and alt improvement. The improvement of TCM symptom score on vomiting, abdominal distension and urine yellow in the treatment group was significantly better than that in the control group, and the improvement of ASTT TBiland Albumin in the treatment group was significantly better than that in the control group; the onset rate of the treatment group was obviously faster than that of the control group. Conclusion the method of removing blood stasis and removing phlegm can effectively improve ASTTBiland Albumin AtroLN in patients with advanced schistosomiasis (giant spleen type), and can effectively relieve the symptoms of vomiting, abdominal distension and urine yellow.
【学位授予单位】:湖北中医药大学
【学位级别】:硕士
【学位授予年份】:2016
【分类号】:R259
【相似文献】
相关期刊论文 前10条
1 蒋敏华;宜兴市晚期血吸虫病情况调查[J];中国血吸虫病防治杂志;2000年03期
2 姜华;;怀宁县晚期血吸虫病调查报告[J];热带病与寄生虫学;2000年01期
3 惠伟东;汪为民;;宣州市205例晚期血吸虫病调查报告[J];热带病与寄生虫学;2000年01期
4 谌火根;病因未治 腹水难消——1例晚期血吸虫病的诊治经过[J];新医学;2001年03期
5 黄涛,杨睿瑶;洪雅县晚期血吸虫病患者调查[J];中国寄生虫学与寄生虫病杂志;2001年06期
6 罗仁寿,舒儒荣,关成梅;潜江市晚期血吸虫病10年调查分析[J];中国血吸虫病防治杂志;2001年04期
7 吴晓华,胡翰亭,高宗保,贺玉川,梅其江,郑江;安徽省宿松县晚期血吸虫病调查分析[J];中国血吸虫病防治杂志;2001年06期
8 蔡宗大,罗仁寿,湛正祥,舒儒荣;潜江市晚期血吸虫病调查分析[J];中国血吸虫病防治杂志;2001年06期
9 季金宝,刘铭堂,王惠民,宋晓明;253例晚期血吸虫病人现状调查分析[J];中国血吸虫病防治杂志;2001年06期
10 冯后喜;51例晚期血吸虫病诊治报告[J];中国血吸虫病防治杂志;2002年03期
相关会议论文 前10条
1 黄德生;马杏宝;蔡黎;;应用减寿分析评价晚期血吸虫病患者死因对人群寿命的影响[A];面向21世纪的科技进步与社会经济发展(下册)[C];1999年
2 王金胜;姜孝渭;;40例晚期血吸虫病癌变原因临床分析[A];第十二届全国肝癌学术会议论文汇编[C];2009年
3 郭见多;李启杨;尹小梅;;晚期血吸虫病人生命质量量表测定分析[A];新世纪预防医学面临的挑战——中华预防医学会首届学术年会论文摘要集[C];2002年
4 牟晓刚;;晚期血吸虫病病人17例分析[A];浙江省第十九届农村卫生改革与发展学术会议大会论文集[C];2011年
5 万腊根;张世锟;胡意;;晚期血吸虫病人凝血功能及血浆D-二聚体调查与分析[A];中华医学会第九次全国检验医学学术会议暨中国医院协会临床检验管理专业委员会第六届全国临床检验实验室管理学术会议论文汇编[C];2011年
6 乌文琳;黄育英;蔡卫民;刘荣华;;344例晚期血吸虫病患者27项血清学指标的检测及其意义(摘要)[A];第九次全国中西医结合肝病学术会议论文集[C];2000年
7 黎明;;奥曲肽对晚期血吸虫病消化道出血的临床疗效观察[A];第十一次全国急诊医学学术会议暨中华医学会急诊医学分会成立二十周年庆典论文汇编[C];2006年
8 吴一鸣;朱志红;徐晓菲;邬万新;朱文军;高树新;许嵩翱;谢新生;王秀娟;;晚期血吸虫病肝纤维化病理特征及肝纤维化进展原因分析[A];2012年浙江省医学会肝病、感染病学学术年会暨浙江省感染科医师学术年会论文集[C];2012年
9 项凤梅;;肝纤维化进展及与晚期血吸虫病的防治[A];全国中西医结合肝病新进展讲习班、江西省第二次中西医结合肝病学术会议资料汇编[C];2010年
10 邱源旺;黄利华;吴鹏飞;华海涌;牛雪花;吴杭源;朱宏英;扬小娟;姚上志;李q诠,
本文编号:1964343
本文链接:https://www.wllwen.com/zhongyixuelunwen/1964343.html